Nearly all astrocytomas with IDH mutation were lower-grade astrocytomas, and the prevalence of MGMT promoter methylation in lower-grade astrocytomas was higher than that in GBM (p=0.032, Fisher's exact test). The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).